Mara, Fynz Aedrifin T.
HRN: 21-61-07 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/16/2023
07/22/2023
IV
150mg
OD
PCAP-D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes